Elicio Therapeutics, Inc. 13D and 13G filings for Elicio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-14 4:04 pm Purchase | 2023-06-01 | 13D | Elicio Therapeutics, Inc. ELTX | Elicio Therapeutics Inc. ELTX | 319,527 3.700% | 319,527 (New Position) | Filing |